Xiaoting Luo
Impact in
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Sarcoma Diagnosis and Treatment 5
-
- Drug Solubulity and Delivery Systems 2
- Advanced Drug Delivery Systems 2
- Co-authors
- Yaping Wang (1 shared paper)Yanyan Zeng (1 shared paper)Yan Heather Lin (1 shared paper)Xing‐Mei Zhang (1 shared paper)Linhan Wang (1 shared paper)Wen Wu (1 shared paper)Hongrui Zhan (1 shared paper)Fang Wang (1 shared paper)
- Journals
- World Journal of Surgical Oncology (2 papers)The Lancet (1 paper)Chemico-Biological Interactions (1 paper)Molecular Therapy — Nucleic Acids (1 paper)ACS Omega (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoting Luo
29 papers receiving 698 citations
Xiaoting Luo's Hit Papers
Peers
Comparison fields: 5 of 84
- Drug Discovery 3
- Neurology 75
- Physiology 91
- Molecular Biology 218
- Hepatology 30
Countries citing papers authored by Xiaoting Luo
This map shows the geographic impact of Xiaoting Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Luo more than expected).
Fields of papers citing papers by Xiaoting Luo
This network shows the impact of papers produced by Xiaoting Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Luo. The network helps show where Xiaoting Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoting Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 147 | |
| 2 | 2016 | 74 | |
| 3 | 2017 | 73 | |
| 4 | Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy Hit paper breakdown → | 2024 | 68 |
| 5 | 2015 | 51 | |
| 6 | 2024 | 37 | |
| 7 | 2017 | 36 | |
| 8 | 2019 | 27 | |
| 9 | 2021 | 26 | |
| 10 | 2018 | 23 | |
| 11 | 2017 | 20 | |
| 12 | 2023 | 20 | |
| 13 | 2022 | 16 | |
| 14 | 2019 | 14 | |
| 15 | 2023 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2024 | 9 | |
| 18 | 2020 | 8 | |
| 19 | 2021 | 8 | |
| 20 | 2023 | 7 |
About Xiaoting Luo
Xiaoting Luo is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science, Molecular Biology, Nephrology and Oncology, having authored 30 papers that have together received 717 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Alzheimer's disease research and treatments (3 papers), Epigenetics and DNA Methylation (3 papers), Drug Solubulity and Delivery Systems (2 papers), Advanced Drug Delivery Systems (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Gut microbiota and health (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Drug Discovery (3 citations), Neurology (75 citations), Physiology (91 citations), Molecular Biology (218 citations) and Hepatology (30 citations). Xiaoting Luo has collaborated with scholars based in China and United States. Frequent co-authors include Yaping Wang, Yanyan Zeng, Yan Heather Lin, Xing‐Mei Zhang, Linhan Wang, Wen Wu, Hongrui Zhan, Fang Wang, Zhenguang Huang and Yun Liu. Their work appears in journals such as World Journal of Surgical Oncology, The Lancet, Chemico-Biological Interactions, Molecular Therapy — Nucleic Acids and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.